rs754533434
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_207122.2(EXT2):c.67C>T(p.Arg23*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000558 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R23R) has been classified as Likely benign.
Frequency
Consequence
NM_207122.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- exostoses, multiple, type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
- seizures-scoliosis-macrocephaly syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary multiple osteochondromasInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EXT2 | NM_207122.2 | c.67C>T | p.Arg23* | stop_gained | Exon 2 of 14 | ENST00000533608.7 | NP_997005.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EXT2 | ENST00000533608.7 | c.67C>T | p.Arg23* | stop_gained | Exon 2 of 14 | 1 | NM_207122.2 | ENSP00000431173.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251444 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Exostoses, multiple, type 2 Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Arg23*) in the EXT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT2 are known to be pathogenic (PMID: 10679937, 19810120). This variant is present in population databases (rs754533434, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with multiple osteochondromas (PMID: 9463333, 25591329, 25744876). It has also been observed to segregate with disease in related individuals. Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this EXT2 variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 50,122 individuals referred to our laboratory for EXT2 testing. ClinVar contains an entry for this variant (Variation ID: 534138). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
- -
Identified in patients with hereditary multiple osteochondromas referred for genetic testing at GeneDx and in published literature (PMID: 9463333, 30334991, 25591329); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 25744876, 30334991, 30806661, 28690282, 9463333, 25591329, 35806987, 29541207) -
Exostoses, multiple, type 2;C4225248:Seizures-scoliosis-macrocephaly syndrome Pathogenic:1
PVS1+PS4+PP4+PP1+PM2_Supporting -
EXT2-related disorder Pathogenic:1
The EXT2 c.67C>T variant is predicted to result in premature protein termination (p.Arg23*). This variant has been reported in individuals with hereditary multiple osteochondromas (HMO) and it has been observed to co-segregate with disease in several families (see for example, Wuyts et al. 1998. PubMed ID: 9463333; Musso et al. 2015. PubMed ID: 25744876; Ruan et al. 2018. PubMed ID: 29541207; Fusco et al. 2019. PubMed ID: 30806661; Kim et al. 2022. PubMed ID: 35806987). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in EXT2 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at